Tag: Patient Safety

Total hip too soon after steroid injection increases SSI risk

Editor's Note The risk of developing a surgical site infection (SSI) increased significantly in patients who had a total hip within 3 months of receiving a steroid injection in the hip joint, finds this study presented March 2 at the annual meeting of the American Academy of Orthopedic Surgeons. Analyzing…

Read More

By: Judy Mathias
March 2, 2016
Share

FDA: Abbott issues safety notice for MitraClip Delivery System

Editor's Note The Food and Drug Administration on February 29 announced a safety notice issued by Abbott (Abbott Park, Illinois) to reinforce the proper procedures used to operate and deploy its MitraClip Delivery System. The company has received nine reports of device malfunction where the user was unable to separate…

Read More

By: Judy Mathias
March 2, 2016
Share

Study: Surgery, anesthesia not associated with cognitive functioning in elderly

Editor's Note This study of 8,503 middle-aged and elderly twins in the Netherlands found no clinically significant association of major surgery and anesthesia with long-term cognitive dysfunction. The findings suggest that preoperative cognitive functioning and underlying diseases have stronger influence on postoperative cognitive abilities. The study provided a powerful approach…

Read More

By: Judy Mathias
March 1, 2016
Share

New use for old drug to reduce blood loss during total joints

Editor's Note An old drug, tranexamic acid (TXA), which has been used in heart surgery, to treat hemophilia, and to stop excessive uterine bleeding is now being used to reduce the need for blood transfusions during total joint replacements. Researchers from the Hospital for Special Surgery in New York City…

Read More

By: Judy Mathias
March 1, 2016
Share

FDA issues Safety Communication on neurosurgical head holders

Editor's Note The Food and Drug Administration (FDA) on February 25 issued a Safety Communication on neurosurgical head holders (skull clamps) and device slippage. From January 2009 to January 2016, the FDA received more than 1,000 reports of slippage or movement of skull clamps before and/or during surgical procedures. The slippage,…

Read More

By: Judy Mathias
February 29, 2016
Share

Study: Colonoscopy reduces cancer, mortality rates

Editor's Note A meta-analysis of 11 studies showed a significant association between patients who had a colonoscopy with nonmalignant findings and reductions in colorectal cancer and mortality rates. Cancer rate reductions were greater for screening colonoscopy than for diagnostic colonoscopy, and results were similar for men and women. One explanation…

Read More

By: Judy Mathias
February 25, 2016
Share

FDA: Facilities should transition from Custom Ultrasonics endoscope reprocessors

Editor's Note The Food and Drug Administration (FDA) on February 23 updated its Safety Communication on the November 2015 recall of Custom Ultrasonics automated endoscope reprocessors. The update recommends that healthcare facilities transition to alternative methods to reprocess flexible endoscopes as soon as possible. In November, the FDA cited violations…

Read More

By: Judy Mathias
February 25, 2016
Share

Study doesn’t support capnography for colonoscopy

Editor's Note Capnographic monitoring during outpatient colonoscopy with moderate sedation increased costs significantly and did not improve patient safety or satisfaction, this study finds. The analysis included 966 patients (465 without and 501 with capnography) who underwent colonoscopy at the Beth Israel Deaconess Medical Center, Boston. Patients and nurses reported…

Read More

By: Judy Mathias
February 23, 2016
Share

AHRQ: New data show 36% increase in mastectomies

Editor's Note Though cancer rates have remained the same, the rate of women having mastectomies increased 36% between 2005 and 2013, according to new data released February 22 by the Agency for Healthcare Research and Quality (AHRQ). The analysis also showed the rate of double mastectomies more than tripling, and…

Read More

By: Judy Mathias
February 23, 2016
Share

FDA: Pentax validates reprocessing instructions for ED-3490 TK Video Duodenoscope

Editor's Note The Food and Drug Administration (FDA) on February 19 announced that it had reviewed updated reprocessing instructions and validation data issued by Pentax Medical (Montvale, New Jersey) for its ED-3490 Video Duodenoscope. The FDA recommends that facilities train staff on the updated instructions and implement them as soon…

Read More

By: Judy Mathias
February 22, 2016
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat